Literature DB >> 2452992

Effects of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II.

R A Cridland1, J L Henry.   

Abstract

The present study examines the effects of intrathecal administration of selected peptides on nociceptive responses in the rat. Each peptide was delivered via a chronically implanted catheter to the L5 vertebral level. In the tail flick test, VIP (0.65-6.5 nmoles) produced a dose-dependent decrease in reaction time (RT) from 1 to 6-16 min after injection; 6.5 nmoles decreased RT to 37% of control value at 1 min after injection. Galanin (0.65-6.5 nmoles) produced a dose-dependent increase in reaction time at 1 and 6 min; at high doses, many of the rats failed to flick the tail. CGRP (6.5 nmoles) produced a small, transient decrease in RT to 73% of control values at 1 min; 3.25 nmoles were without effect. CSF and 6.5 nmoles of somatostatin, TRH and angiotensin II were without effect. At high doses of galanin and CGRP, rats vocalized to innocuous touch of the tail, as reported for substance P. Von Frey hairs were thus applied to the tail after 6.5 nmoles of VIP, galanin, CGRP or substance P. Vocalization in response to a previously innocuous pressure stimulus was observed at 30 s after injection in all rats given galanin and some rats given CGRP or substance P; the effect lasted 4-8 min. VIP and CSF had no effect. These results suggest that VIP, galanin, CGRP and substance P may act as excitatory agents in nociceptive pathways and that specific peptides may function in the different types of pain modalities; VIP in thermal, galanin in mechanical and substance P and CGRP in both.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452992     DOI: 10.1016/0143-4179(88)90024-8

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  24 in total

1.  Neuropathy-induced spinal GAP-43 expression is not a main player in the onset of mechanical pain hypersensitivity.

Authors:  Robby J Jaken; Sebastiaan van Gorp; Elbert A Joosten; Mario Losen; Pilar Martínez-Martínez; Marc De Baets; Marco A Marcus; Ronald Deumens
Journal:  J Neurotrauma       Date:  2011-10-20       Impact factor: 5.269

2.  Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.

Authors:  Paul L Durham; Carrie V Vause
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

3.  A role for adrenomedullin as a pain-related peptide in the rat.

Authors:  Weiya Ma; Jean-Guy Chabot; Remi Quirion
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

4.  Electrophysiological studies on rat dorsal root ganglion neurons after peripheral axotomy: changes in responses to neuropeptides.

Authors:  Z Q Xu; X Zhang; S Grillner; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Keratinocyte expression of calcitonin gene-related peptide β: implications for neuropathic and inflammatory pain mechanisms.

Authors:  Quanzhi Hou; Travis Barr; Lucy Gee; Jeff Vickers; James Wymer; Elisa Borsani; Luigi Rodella; Spiro Getsios; Trisha Burdo; Elan Eisenberg; Udayan Guha; Robert Lavker; John Kessler; Sridar Chittur; Dennis Fiorino; Frank Rice; Phillip Albrecht
Journal:  Pain       Date:  2011-06-17       Impact factor: 6.961

6.  Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats.

Authors:  Jeong S Han; Hita Adwanikar; Zhen Li; Guangchen Ji; Volker Neugebauer
Journal:  Mol Pain       Date:  2010-02-08       Impact factor: 3.395

7.  Characterisation of the nociceptive phenotype of suppressible galanin overexpressing transgenic mice.

Authors:  Robert J P Pope; Fiona E Holmes; Niall C Kerr; David Wynick
Journal:  Mol Pain       Date:  2010-10-21       Impact factor: 3.395

8.  Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice.

Authors:  Blanca Marquez de Prado; Donna L Hammond; Andrew F Russo
Journal:  J Pain       Date:  2009-07-22       Impact factor: 5.820

9.  Transgenic overexpression of galanin in the dorsal root ganglia modulates pain-related behavior.

Authors:  Fiona E Holmes; Andrea Bacon; Robert J P Pope; Penny A Vanderplank; Niall C H Kerr; Madhu Sukumaran; Vassilis Pachnis; David Wynick
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

10.  Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism.

Authors:  J Gibbs; C M Flores; K M Hargreaves
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.